Lisa Gill
Stock Analyst at JP Morgan
(3.40)
# 1,006
Out of 4,996 analysts
128
Total ratings
50%
Success rate
4.21%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
MCK McKesson | Maintains: Overweight | $821 → $853 | $760.55 | +12.16% | 14 | Sep 26, 2025 | |
AVAH Aveanna Healthcare Holdings | Upgrades: Neutral | $6 → $10 | $8.75 | +14.29% | 3 | Sep 18, 2025 | |
OMI Owens & Minor | Maintains: Underweight | $7 → $6 | $4.77 | +25.79% | 5 | Aug 27, 2025 | |
UNH UnitedHealth Group | Maintains: Overweight | $418 → $310 | $344.08 | -9.90% | 9 | Aug 6, 2025 | |
ELV Elevance Health | Maintains: Overweight | $472 → $384 | $318.61 | +20.52% | 5 | Jul 22, 2025 | |
PRVA Privia Health Group | Maintains: Overweight | $29 → $32 | $23.98 | +33.44% | 5 | May 28, 2025 | |
DGX Quest Diagnostics | Maintains: Neutral | $180 → $190 | $188.99 | +0.53% | 3 | May 6, 2025 | |
CON Concentra Group Holdings Parent | Maintains: Overweight | $29 → $30 | $20.82 | +44.09% | 2 | Mar 19, 2025 | |
OPCH Option Care Health | Maintains: Overweight | $40 → $41 | $27.30 | +50.18% | 4 | Mar 6, 2025 | |
ALHC Alignment Healthcare | Maintains: Neutral | $14 → $17 | $17.53 | -3.02% | 4 | Mar 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $257 → $256 | $254.95 | +0.41% | 6 | Feb 18, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $81 | $75.77 | +6.90% | 5 | Feb 18, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $142 → $145 | $153.71 | -5.67% | 6 | Feb 4, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $289 → $301 | $307.00 | -1.95% | 2 | Jan 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $18 | $13.98 | +28.76% | 2 | Dec 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $5 | $4.79 | +4.38% | 4 | Dec 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $28 | $21.84 | +28.21% | 4 | Dec 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $9 | $8.16 | +10.29% | 9 | Aug 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $438 | $286.17 | +53.06% | 13 | Aug 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $13.26 | +35.75% | 1 | Aug 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $395 | $191.98 | +105.75% | 2 | Jul 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $261 → $243 | $280.61 | -13.40% | 1 | May 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $182 → $186 | $200.85 | -7.39% | 1 | May 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $107 → $140 | $202.00 | -30.69% | 1 | May 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $327 → $332 | $419.08 | -20.78% | 3 | May 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $7 → $10 | $4.04 | +147.52% | 1 | Mar 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $17 → $9 | $1.09 | +725.69% | 3 | Jan 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $8 | $5.42 | +47.60% | 4 | Nov 17, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $83 | $66.04 | +25.68% | 1 | Aug 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $98 | $34.86 | +181.12% | 1 | Jan 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $27.81 | - | 4 | Dec 19, 2017 |
McKesson
Sep 26, 2025
Maintains: Overweight
Price Target: $821 → $853
Current: $760.55
Upside: +12.16%
Aveanna Healthcare Holdings
Sep 18, 2025
Upgrades: Neutral
Price Target: $6 → $10
Current: $8.75
Upside: +14.29%
Owens & Minor
Aug 27, 2025
Maintains: Underweight
Price Target: $7 → $6
Current: $4.77
Upside: +25.79%
UnitedHealth Group
Aug 6, 2025
Maintains: Overweight
Price Target: $418 → $310
Current: $344.08
Upside: -9.90%
Elevance Health
Jul 22, 2025
Maintains: Overweight
Price Target: $472 → $384
Current: $318.61
Upside: +20.52%
Privia Health Group
May 28, 2025
Maintains: Overweight
Price Target: $29 → $32
Current: $23.98
Upside: +33.44%
Quest Diagnostics
May 6, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $188.99
Upside: +0.53%
Concentra Group Holdings Parent
Mar 19, 2025
Maintains: Overweight
Price Target: $29 → $30
Current: $20.82
Upside: +44.09%
Option Care Health
Mar 6, 2025
Maintains: Overweight
Price Target: $40 → $41
Current: $27.30
Upside: +50.18%
Alignment Healthcare
Mar 6, 2025
Maintains: Neutral
Price Target: $14 → $17
Current: $17.53
Upside: -3.02%
Feb 18, 2025
Maintains: Neutral
Price Target: $257 → $256
Current: $254.95
Upside: +0.41%
Feb 18, 2025
Maintains: Overweight
Price Target: $80 → $81
Current: $75.77
Upside: +6.90%
Feb 4, 2025
Maintains: Neutral
Price Target: $142 → $145
Current: $153.71
Upside: -5.67%
Jan 24, 2025
Maintains: Overweight
Price Target: $289 → $301
Current: $307.00
Upside: -1.95%
Dec 17, 2024
Downgrades: Neutral
Price Target: $18
Current: $13.98
Upside: +28.76%
Dec 17, 2024
Downgrades: Underweight
Price Target: $5
Current: $4.79
Upside: +4.38%
Dec 3, 2024
Maintains: Neutral
Price Target: $38 → $28
Current: $21.84
Upside: +28.21%
Aug 26, 2024
Maintains: Neutral
Price Target: $16 → $9
Current: $8.16
Upside: +10.29%
Aug 21, 2024
Maintains: Overweight
Price Target: $435 → $438
Current: $286.17
Upside: +53.06%
Aug 12, 2024
Initiates: Neutral
Price Target: $18
Current: $13.26
Upside: +35.75%
Jul 10, 2024
Maintains: Overweight
Price Target: $420 → $395
Current: $191.98
Upside: +105.75%
May 30, 2024
Maintains: Overweight
Price Target: $261 → $243
Current: $280.61
Upside: -13.40%
May 30, 2024
Maintains: Neutral
Price Target: $182 → $186
Current: $200.85
Upside: -7.39%
May 30, 2024
Maintains: Overweight
Price Target: $107 → $140
Current: $202.00
Upside: -30.69%
May 30, 2024
Maintains: Neutral
Price Target: $327 → $332
Current: $419.08
Upside: -20.78%
Mar 1, 2024
Upgrades: Overweight
Price Target: $7 → $10
Current: $4.04
Upside: +147.52%
Jan 5, 2024
Downgrades: Neutral
Price Target: $17 → $9
Current: $1.09
Upside: +725.69%
Nov 17, 2023
Maintains: Neutral
Price Target: $10 → $8
Current: $5.42
Upside: +47.60%
Aug 9, 2023
Maintains: Neutral
Price Target: $80 → $83
Current: $66.04
Upside: +25.68%
Jan 6, 2023
Maintains: Overweight
Price Target: $103 → $98
Current: $34.86
Upside: +181.12%
Dec 19, 2017
Downgrades: Neutral
Price Target: n/a
Current: $27.81
Upside: -